scholarly journals Neuropsychiatry and White Matter Microstructure in Huntington’s Disease

2015 ◽  
Vol 4 (3) ◽  
pp. 239-249 ◽  
Author(s):  
Sarah Gregory ◽  
Rachael I. Scahill ◽  
Kiran K. Seunarine ◽  
Cheryl Stopford ◽  
Hui Zhang ◽  
...  
2014 ◽  
Vol 85 (Suppl 1) ◽  
pp. A40-A41
Author(s):  
G. Poudel ◽  
J. Stout ◽  
J. Dominguez ◽  
A. Churchyard ◽  
P. Chua ◽  
...  

2014 ◽  
Vol 3 (3) ◽  
pp. 273-283 ◽  
Author(s):  
Claudia Metzler-Baddeley ◽  
Jaime Cantera ◽  
Elizabeth Coulthard ◽  
Anne Rosser ◽  
Derek K. Jones ◽  
...  

2015 ◽  
Vol 74 ◽  
pp. 406-412 ◽  
Author(s):  
Govinda R. Poudel ◽  
Julie C. Stout ◽  
Juan F. Domínguez D. ◽  
Andrew Churchyard ◽  
Phyllis Chua ◽  
...  

2018 ◽  
Vol 39 (9) ◽  
pp. 3516-3527 ◽  
Author(s):  
Sarah Gregory ◽  
Helen Crawford ◽  
Kiran Seunarine ◽  
Blair Leavitt ◽  
Alexandra Durr ◽  
...  

NeuroImage ◽  
2010 ◽  
Vol 49 (4) ◽  
pp. 2995-3004 ◽  
Author(s):  
H. Diana Rosas ◽  
Stephanie Y. Lee ◽  
Alexander C. Bender ◽  
Alexandra K. Zaleta ◽  
Mark Vangel ◽  
...  

2016 ◽  
Vol 87 (Suppl 1) ◽  
pp. A39.2-A39
Author(s):  
Helen Crawford ◽  
Douglas R Langbehn ◽  
Rachael I Scahill ◽  
Geraint Rees ◽  
Sarah J Tabrizi ◽  
...  

2019 ◽  
Author(s):  
chiara casella ◽  
Claudia Metzler-Baddeley ◽  
Derek Jones ◽  
Ilona Lipp

Huntington’s disease (HD) is a genetic neurodegenerative disorder, characterised by atrophy of the neostriatum, and cortical grey matter abnormalities. White matter (WM) alterations have recently been identified as a relevant pathophysiological feature of HD, but the etiology of WM degeneration, and its role in disease pathogenesis and progression remain unclear. An increasing body of research suggests that WM changes in HD are due to alterations in myelin-associated biological processes at the cellular and molecular level. This review first discusses evidence from neurochemical studies lending support to the ‘De-myelination hypothesis’ of HD, and pointing towards a role for aberrant myelination and changes in oligodendrocytes in HD WM. Next, evidence from neuroimaging studies is reviewed, the limitations of the described methodologies are discussed and suggested interpretations of findings from published studies are challenged. Although our understanding of HD-associated pathological changes in the brain will increasingly rely on neuroimaging techniques, the shortcomings of these methodologies must not be forgotten. Advances in MRI techniques and tissue modeling will enable a better characterization of the biological properties of WM microstructure, and will allow more specific monitoring of longitudinal changes noninvasively. This, in turn, will provide insight into disease pathogenesis and progression and facilitate the identification of disease-related biomarkers and the specification of outcome measures in clinical trials.


2016 ◽  
Vol 37 (12) ◽  
pp. 4615-4628 ◽  
Author(s):  
Michael Orth ◽  
Sarah Gregory ◽  
Rachael I Scahill ◽  
Isabella SM Mayer ◽  
Lora Minkova ◽  
...  

2018 ◽  
Author(s):  
Audrey E De Paepe ◽  
Joanna Sierpowska ◽  
Clara García-Gorro ◽  
Saül Martinez-Horta ◽  
Jesus Perez-Perez ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document